Following Sonova and Demant’s guidance downgrades, there has been a panic across the board with all hearing aid stocks in our coverage down 4-14%. While Sonova has fallen 14%, we believe this sell-off opens up a big window of opportunity, given that the Swiss firm remains the sector’s top-innovator and has the underlying strength to navigate the current market challenges. Overall, while our estimates for hearing aid stocks are likely to be trimmed, Sonova remains our top sector-pick.
16 Aug 2022
Guidance downgrades trigger sector-wide panic
Sign up to access
Get access to our full offering from over 30 providers
Get access to our full offering from over 30 providers
Guidance downgrades trigger sector-wide panic
Following Sonova and Demant’s guidance downgrades, there has been a panic across the board with all hearing aid stocks in our coverage down 4-14%. While Sonova has fallen 14%, we believe this sell-off opens up a big window of opportunity, given that the Swiss firm remains the sector’s top-innovator and has the underlying strength to navigate the current market challenges. Overall, while our estimates for hearing aid stocks are likely to be trimmed, Sonova remains our top sector-pick.